Position in ARWR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$319,519
-$85,691 QoQ
Shares Held
3,920
-74.9% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#342
of 497 holders
Holding Since
Jun 2023
6 quarters on record
Voting authority
Sole 28%
Shared 0%
None 72%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lido Advisors, LLC holds $48,509,639 across 38 Biotechnology names. ARWR ranks #19 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
45,347 | $22,525,214 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
11,647 | $7,262,370 | |
| 3 | INCY |
Incyte Corp
|
18,327 | $2,077,548 | |
| 4 | IDYA |
IDEAYA Biosciences, Inc.
|
51,212 | $1,908,671 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
8,476 | $1,587,385 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
24,322 | $1,530,826 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,158 | $1,410,609 | |
| 8 | MRNA |
Moderna, Inc.
|
16,522 | $1,157,035 |
All Filings in ARWR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $319,519 | 3,920 | Shares | Sole | 2026-08-07 | |
| 2024-06-30 | $405,210 | 15,591 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $446,503 | 15,612 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $477,084 | 15,591 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $424,868 | 15,812 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $551,660 | 15,470 | Shares | Sole | 2023-08-09 | |
| No filing history on record for this holder in this stock. | ||||||